News
Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with ...
Zacks Investment Research on MSN20h
Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline UpdateNovo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...
AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 20,457.50 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback